NCT01010750 - Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 5, 2010

Primary Completion Date

March 28, 2010

Study Completion Date

March 28, 2010

Conditions

Attention-Deficit Hyperactivity Disorder

Interventions

DRUG

Lisdexamfetamine Dimesylate (LDX)

Lisdexamfetamine Dimesylate (LDX) + Immediate Release Mixed Amphetamine Salts (MAS-IR) placebo

DRUG

Immediate Release Mixed Amphetamine Salts (MAS-IR)

Immediate Release Mixed Amphetamine Salts (MAS-IR) + Lisdexamfetamine Dimesylate (LDX) placebo

DRUG

LDX Placebo + MAS-IR Placebo

Lisdexamfetamine Dimesylate (LDX) Placebo + Immediate Release Mixed Amphetamine Salts (MAS-IR) Placebo

Trial Locations (1)

Claghorn-Lesem Research Clinic, Houston